Search results
Results from the WOW.Com Content Network
ASCIA was formed in 1991 by the merging of the Australian College of Allergy with the Australasian Society of Immunology Clinical Immunology Group. [ 1 ] ASCIA publishes guidelines and position statements on the management of allergy and other immune diseases, provides online training courses, online educational resources, hosts the ASCIA ...
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
Ann Janet Woolcock (11 December 1937 – 17 February 2001) was an Australian respiratory physician–scientist and one of the world's leading asthma experts. She contributed greatly to the field of asthma research and founded the Institute of Respiratory Medicine, Sydney, which is now known as the Woolcock Institute of Medical Research.
Later research found that the combination was no more effective for asthma than theophylline alone but produced more side effects. [ 9 ] [ 1 ] [ 12 ] [ 7 ] Combinations of theophylline, ephedrine, and phenobarbital (brand name Tedral among others) have also been widely used to treat asthma.
Australian Medicines Handbook (AMH) is a peer-reviewed medicines prescribing guide for Australian health professionals. The handbook is available in paper and digital formats and is supplemented by the AMH Aged Care Companion and the AMH Children's Dosing Companion. It is included in the Clinical Information Access Portal.
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
The medical uses for Cysteinyl-leukotriene type 1 receptor antagonists are for chronic and prophylactic treatment of asthma. [3] [9] [10] Other indications have been approved by the FDA for montelukast and they are used for the prevention of exercise-induced bronchoconstriction (EIB), relief of symptoms of allergic rhinitis (AR) that is for relief of seasonal allergic rhinitis and perennial ...
Clenbuterol is approved for use in some countries as a bronchodilator for asthma. [medical citation needed]Clenbuterol is a β 2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol, but its effects are more potent and longer-lasting as a stimulant and thermogenic drug.